Compare ALAR & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALAR | ECOR |
|---|---|---|
| Founded | 2013 | 2005 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.7M | 49.1M |
| IPO Year | 2018 | 2018 |
| Metric | ALAR | ECOR |
|---|---|---|
| Price | $6.96 | $6.16 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | $14.00 | ★ $18.00 |
| AVG Volume (30 Days) | 29.8K | ★ 61.3K |
| Earning Date | 05-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $32,032,000.00 |
| Revenue This Year | $24.51 | $33.60 |
| Revenue Next Year | $33.43 | $30.40 |
| P/E Ratio | $44.31 | ★ N/A |
| Revenue Growth | N/A | ★ 27.20 |
| 52 Week Low | $5.50 | $4.16 |
| 52 Week High | $18.00 | $8.55 |
| Indicator | ALAR | ECOR |
|---|---|---|
| Relative Strength Index (RSI) | 55.23 | 46.06 |
| Support Level | $6.34 | $4.61 |
| Resistance Level | $7.76 | $7.57 |
| Average True Range (ATR) | 0.46 | 0.53 |
| MACD | 0.11 | -0.03 |
| Stochastic Oscillator | 65.10 | 27.92 |
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment: web data collection. Geographically, it derives maximum revenue from China, followed by the United States, Europe, Hong Kong, Asia-Pacific, U.K. Virgin Islands, Israel, United Arab Emirates, Middle East & Africa and other.
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.